SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-043153
Filing Date
2020-04-03
Accepted
2020-04-03 16:44:17
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a20-14952_110ka.htm 10-K/A 397318
2 EX-31.1 a20-14952_1ex31d1.htm EX-31.1 6073
3 EX-31.2 a20-14952_1ex31d2.htm EX-31.2 6086
4 GRAPHIC g149521bai001.jpg GRAPHIC 1598
  Complete submission text file 0001104659-20-043153.txt   412815
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37926 | Film No.: 20774091
SIC: 2834 Pharmaceutical Preparations